IL36G Human

Interleukin-36 Gamma Human Recombinant
Cat. No.
BT16380
Source
Escherichia Coli.
Synonyms
Interleukin 36 gamma, IL1F9, interleukin 1 family member 9, Interleukin-1 epsilon, IL-1RP2, IL-1H1, IL1E, interleukin 1-related protein 2, Interleukin-1 homolog 1.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

IL36G Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 169 amino acids and having a molecular mass of 18.7kDa.
The IL36G is purified by proprietary chromatographic techniques.

Product Specs

Introduction
IL-36 gamma (IL-36γ) is a cytokine that belongs to the IL-1 family. This family includes other inflammatory mediators such as IL-1β, IL-1α, IL-1ra, IL-18, IL-36 Ra (IL-1F5), IL-36α (IL-1F6), IL-36β (IL-1F8), IL-37 (IL-1F7), and IL-1F10. These family members share a similar structure, characterized by a 12 β-strand, β-trefoil configuration, and are believed to have originated from a common ancestral gene. IL-36γ is an 18-22 kDa protein composed of 169 amino acids. It exists in both intracellular and secreted forms and lacks a signal sequence, a prosegment, and potential N-linked glycosylation sites. Notably, human IL-36γ exhibits a high degree of amino acid sequence homology with its counterparts in other mammals, ranging from 58% to 69% with mouse, rat, bovine, and equine IL-36γ. However, it shares a lower sequence homology of 23% to 57% with other members of the IL-1 family. The receptor for IL-36γ comprises two subunits: IL-1 Rrp2, which is primarily found on epithelial cells and keratinocytes, and IL-1 RAcP, which is ubiquitously expressed. The binding of IL-36γ to its receptor triggers the activation of downstream signaling pathways, including NF-κB and MAPK pathways, ultimately leading to the production of various inflammatory cytokines and chemokines such as CXCL8/IL-8.
Description
Recombinant human IL-36γ, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 169 amino acids. This protein has a molecular weight of 18.7 kDa and is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder
Formulation
Lyophilized from a 0.2 µm filtered solution in phosphate-buffered saline (PBS) at a pH of 7.4 with 5% trehalose.
Solubility
To reconstitute the lyophilized IL-36γ, it is recommended to dissolve it in sterile, ultrapure water (18 MΩ·cm) at a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized human IL-36γ is stable at room temperature for up to 3 weeks; however, for long-term storage, it is recommended to store it in a dry environment below -18°C. After reconstitution, IL-36γ should be stored at 4°C for no longer than 2-7 days. For long-term storage, it is advisable to store it below -18°C. It's important to note that repeated freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 95% through the following methods: (a) Analysis by reverse-phase high-performance liquid chromatography (RP-HPLC), (b) Analysis by sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Biological Activity
The biological activity of recombinant human IL-36γ is evaluated through its binding affinity to the recombinant human IL-1 Rrp2 Fc chimera protein. This is assessed using a functional enzyme-linked immunosorbent assay (ELISA).
Synonyms
Interleukin 36 gamma, IL1F9, interleukin 1 family member 9, Interleukin-1 epsilon, IL-1RP2, IL-1H1, IL1E, interleukin 1-related protein 2, Interleukin-1 homolog 1.
Source
Escherichia Coli.
Amino Acid Sequence
MRGTPGDADG GGRAVYQSMC KPITGTINDL NQQVWTLQGQ NLVAVPRSDS VTPVTVAVIT CKYPEALEQG RGDPIYLGIQ NPEMCLYCEK VGEQPTLQLK EQKIMDLYGQ PEPVKPFLFY RAKTGRTSTL ESVAFPDWFI ASSKRDQPII LTSELGKSYN TAFELNIND

Product Science Overview

Introduction

Interleukin-36 Gamma (IL-36γ) is a member of the interleukin-1 (IL-1) superfamily, which includes a variety of cytokines involved in inflammatory and immune responses. IL-36γ, along with IL-36α and IL-36β, functions as an agonist, while IL-36Ra acts as an antagonist . These cytokines play crucial roles in modulating the immune system and are implicated in various inflammatory diseases.

Structure and Signaling

IL-36γ is a protein encoded by the IL36G gene located on human chromosome 2 . The IL-36 family members share structural similarities with other IL-1 cytokines, including a conserved β-trefoil fold. IL-36γ binds to the IL-36 receptor (IL-36R), which is a heterodimer composed of IL-1 receptor-related protein 2 (IL-1Rrp2) and the IL-1 receptor accessory protein (IL-1RAcP) . Upon binding to IL-36R, IL-36γ activates downstream signaling pathways, including the nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways .

Biological Functions

IL-36γ is primarily expressed in epithelial cells, keratinocytes, and various immune cells . It plays a significant role in the regulation of immune responses, particularly in the skin, lungs, and gastrointestinal tract. IL-36γ is involved in the activation of immune cells, antigen presentation, and the production of pro-inflammatory cytokines and chemokines . It contributes to host defense mechanisms by promoting inflammation and enhancing the immune response.

Role in Inflammatory Diseases

Dysregulation of IL-36γ has been associated with several inflammatory diseases, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease . In psoriasis, IL-36γ stimulates keratinocytes and immune cells, leading to the activation of the Th17/Th23 axis and the development of psoriatic lesions . Genetic mutations in the IL36RN gene, which encodes the IL-36Ra antagonist, are linked to generalized pustular psoriasis, a severe and life-threatening form of the disease .

Therapeutic Potential

Given its role in inflammatory diseases, IL-36γ has emerged as a potential therapeutic target. Anti-IL-36 antibodies have shown promise in preclinical studies, where they attenuated skin inflammation in mouse models of psoriasis . Further research is needed to explore the therapeutic potential of targeting IL-36γ in other inflammatory conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.